NewAmsterdam Pharma Co NV (NAMS)
21.43
-0.43
(-1.97%)
USD |
NASDAQ |
May 10, 16:00
21.44
+0.02
(+0.07%)
After-Hours: 20:00
NewAmsterdam Pharma Market Cap: 1.913B for May 10, 2024
Market Cap Chart
Historical Market Cap Data
| Date | Value |
|---|---|
| May 10, 2024 | 1.913B |
| May 09, 2024 | 1.951B |
| May 08, 2024 | 1.945B |
| May 07, 2024 | 1.982B |
| May 06, 2024 | 1.951B |
| May 03, 2024 | 1.948B |
| May 02, 2024 | 2.015B |
| May 01, 2024 | 1.961B |
| April 30, 2024 | 1.947B |
| April 29, 2024 | 1.934B |
| April 26, 2024 | 1.963B |
| April 25, 2024 | 1.914B |
| April 24, 2024 | 1.946B |
| April 23, 2024 | 1.915B |
| April 22, 2024 | 1.806B |
| April 19, 2024 | 1.779B |
| April 18, 2024 | 1.735B |
| April 17, 2024 | 1.790B |
| April 16, 2024 | 1.741B |
| April 15, 2024 | 1.762B |
| April 12, 2024 | 1.759B |
| April 11, 2024 | 1.779B |
| April 10, 2024 | 1.705B |
| April 09, 2024 | 1.692B |
| April 08, 2024 | 1.751B |
| Date | Value |
|---|---|
| April 05, 2024 | 1.857B |
| April 04, 2024 | 1.911B |
| April 03, 2024 | 1.974B |
| April 02, 2024 | 1.910B |
| April 01, 2024 | 1.908B |
| March 28, 2024 | 2.111B |
| March 27, 2024 | 2.026B |
| March 26, 2024 | 2.028B |
| March 25, 2024 | 2.005B |
| March 22, 2024 | 1.988B |
| March 21, 2024 | 2.004B |
| March 20, 2024 | 1.976B |
| March 19, 2024 | 1.968B |
| March 18, 2024 | 1.967B |
| March 15, 2024 | 1.967B |
| March 14, 2024 | 1.958B |
| March 13, 2024 | 1.991B |
| March 12, 2024 | 2.092B |
| March 11, 2024 | 1.869B |
| March 08, 2024 | 1.872B |
| March 07, 2024 | 1.867B |
| March 06, 2024 | 1.967B |
| March 05, 2024 | 1.988B |
| March 04, 2024 | 2.058B |
| March 01, 2024 | 2.101B |
Market Capitalization Definition
Market Capitalization measures the total value of a company based on their stock price multiplied by the shares outstanding. This metric is important because it gives you an idea of the size of a company, and how the size has changed over time. When studying companies from a relative basis, it would make sense to compare companies that have a similar market capitalization because factors like market share, economies of scale, and business models would also be similar.
Market Cap Range, Past 5 Years
492.30M
Minimum
Oct 25 2023
2.163B
Maximum
Feb 27 2024
1.141B
Average
995.54M
Median
Jun 29 2023
Market Cap Benchmarks
| NovaBay Pharmaceuticals Inc | 2.420M |
| Palatin Technologies Inc | 36.95M |
| iBio Inc | 6.446M |
| Theriva Biologics Inc | 6.289M |
| Oragenics Inc | 8.244M |
Market Cap Related Metrics
| PS Ratio | 124.96 |
| Price to Book Value | 6.633 |
| Price | 21.43 |
| Earnings Yield | -10.03% |